Stanley Szefler, MD
Professor, Pediatrics-Pulmonary Medicine

Director - Pediatric Asthma Research Program, Breathing Institute
Interim Medical Director, Research Institute
Clinic (720) 777-6181
Print Profile
Email Profile
Featured Provider Photo

Gender: Male
Languages: English
Department, Section/Division: Pediatrics-Pulmonary Medicine

Practice Locations

Children's Hospital Colorado Anschutz Medical Campus
13123 East 16th Ave
Aurora, CO 80045
720-777-1234
More providers at this location

Hospital Affiliation
  • Children's Hospital Colorado

Specialty Information

Specialties
  • Allergy and Immunology, Board Certification
  • Pediatrics, Board Certification
Conditions & Treatments
  • Immune System
  • Allergies
  • Lungs and Breathing
  • Asthma
Clinical Interest for Patients
I am interested in Childhood asthma; Asthma pharmacotherapy; Inhaled corticosteroids; Biomarkers; Predictors of treatment response and Monitoring treatment response; School-centered asthma programs.

Education & Training

Medical Schools:
  • MD, State University of New York - Buffalo (1975)

Undergraduate Schools:
  • BSc, State University of New York at Buffalo (NY) (1971)

Internships:
  • University at Buffalo School of Medicine Program (1976)

Residency Program:
  • University at Buffalo School of Medicine Program, Pediatrics (1977)

Fellowships:
  • Women and Children's Hospital of Buffalo/University at Buffalo Program, Clinical Pharmacology and Allergy and Immunology (1979)

Professional Memberships

  • American Academy of Allergy Asthma and Immunology , Member
  • American Academy of Pediatrics (AAP), Member
  • American College of Allergy, Asthma and Immunology , Member
  • American Society of Pharmacology and Experimental Therapeutics , Member
  • American Thoracic Society (ATS), Member
  • Colorado Allergy Society , Member
  • Colorado Trudeau Society/Medical Section of the American Lung Association of Colorado , Member
  • Society of Pediatric Research , Member

Teaching

  • Professor (1982)
    School of Medicine, Pediatrics
    My area of interest is pediatric respiratory disease, especially childhood asthma.

Research & Grants

http://www.ncbi.nlm.nih.gov/pubmed?term="Szefler SJ"[Author]
Grants
  • Reducing Asthma Attacks in Disadvantaged School Children with Asthma (2020)
    National Heart, Lung and Blood Institute, $2700000
  • Colorado Comprehensive School-centered Asthma Program (AsthmaCOMP) (2018)
    Colorado Department of Public Health and Environment, $2500000
  • Precision Interventions for Severe and/or Exacerbation Prone Asthma (PrecISE) (2017)
    National, Heart, Lung and Blood Institute, $343,740
Research interests for Patients:
Dr. Szefler's major contributions are directed toward the appropriate use of long-term control therapy in asthma, including the recognition of variability in response to asthma therapy. He has identified biomarkers and asthma characteristics that can be used to predict and thus individualize asthma therapy. Dr. Szefler is the Director of the Pediatric Asthma Research Program and Research Medical Director in the Breathing Institute of the Pediatric Pulmonary Section at Children's Hospital Colorado. He is also Professor of Pediatrics at the University of Colorado Denver School of Medicine. He is also a former member of the Expert Panel for the National Heart, Lung, and Blood Institute's National Asthma Education and Prevention Program on "Guidelines for the Diagnosis and Management of Asthma" and a former member of the Global Initiative for Asthma Science Committee. From 1997 through 2018 he served as Deputy Editor for the Journal of Allergy and Clinical Immunology. He has published more than 600 scientific articles and co-edited books on severe asthma, childhood asthma and pediatric allergy and immunology and personalized medicine. He is the Co-Principal Investigator for the NHLBI PrecISE Network that is focused on identifying new treatment for severe and exacerbation prone asthma. He is the Co-Principal Investigator for the NHLBI DECIPHeR Alliance that is designed to reduce health disparities by improving asthma control in disadvantaged children. For the past fifteen years, he has directed a school-based asthma program for the Denver Public School system funded by the Colorado Department of Public Health and Environment Colorado Cancer, Cardiovascular and Pulmonary Disease Program. This program seeks to define the prevalence and severity of asthma, identify those most significantly affected, and to direct those children to state of the art asthma care. The program was recently awarded a NHLBI UG3 dissemination and implementation grant (DECIPHeR) to assess the feasibility of extending the school-centered asthma program to 5 regional hubs in Colorado.

Information for Referring Providers

Clinical Interests for Referring Providers
I am interested in Childhood asthma; Asthma pharmacotherapy; Inhaled corticosteroids; Biomarkers; Predictors of treatment response and Monitoring treatment response; School-Centered asthma programs.

Research Interest for Referring Providers
Dr. Szefler’s major contributions are directed toward the appropriate use of long-term control therapy in asthma, including the recognition of variability in response to asthma therapy. He has identified biomarkers and asthma characteristics that can be used to predict and thus individualize asthma therapy. Dr. Szefler is the Director of the Pediatric Asthma Research Program and Research Medical Director in the Breathing Institute of the Pediatric Pulmonary and Sleep Medicine Section and Interim Medical Director for the Research Institute at Children’s Hospital Colorado. He is also Professor of Pediatrics with Tenure at the University of Colorado Denver School of Medicine. He is a former member of the Expert Panel for the National Heart, Lung, and Blood Institute’s National Asthma Education and Prevention Program on “Guidelines for the Diagnosis and Management of Asthma” and a former member of the Global Initiative for Asthma Science Committee. From 1997 through 1998, he was a Deputy Editor for the Journal of Allergy and Clinical Immunology. He has published more than 600 scientific articles and co-edited books on severe asthma, childhood asthma, pediatric allergy and immunology and personalized asthma management for clinicians. He is the Co-Principal Investigator for the NHLBI DECIPHeR Alliance that is designed to reduce health disparities by improving asthma control in disadvantaged children. For the past fifteen years, he has directed a school-based asthma program for the Denver Public School system funded by the Colorado Department of Public Health and Environment Colorado Cancer, Cardiovascular and Pulmonary Disease Program. This program seeks to define the prevalence and severity of asthma, identify those most significantly affected, and to direct those children to state of the art asthma care. This program also developed a mentorship program for school nurses and was supported by Glaxo Smith Kline in order to set a national standard for school-based asthma management. The program was recently awarded a NHLBI UG3 dissemination and implementation grant (DECIPHeR) to assess the feasibility of extending the school-centered asthma program to 5 regional hubs in Colorado.
Clinic Phone: (720) 777-6181
Fax Phone: (720) 777-7284

CV cv szefler update 012921.docx